Clinical trial
Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
NCT02468336 is registered in ClinicalTrials.gov with Everist Genomics, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vascular Reactivity Assessment by a Novel Diagnostic Device, ANGIODEFENDER, Compared to Using Brachial Artery Ultrasound Imaging
- Lead sponsor
- Everist Genomics, Inc
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2015
- Completion date
- February 15, 2017
- Enrollment
- 171 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.